FI964045A0 - CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä - Google Patents

CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä

Info

Publication number
FI964045A0
FI964045A0 FI964045A FI964045A FI964045A0 FI 964045 A0 FI964045 A0 FI 964045A0 FI 964045 A FI964045 A FI 964045A FI 964045 A FI964045 A FI 964045A FI 964045 A0 FI964045 A0 FI 964045A0
Authority
FI
Finland
Prior art keywords
gastrin
cck
benzodiazepines
heterocycle
regulating
Prior art date
Application number
FI964045A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI964045A (fi
Inventor
Christopher Joseph Aquino
Elizabeth Ellen Sugg
Jerzy Ryszard Szewczyk
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9407433A external-priority patent/GB9407433D0/en
Priority claimed from GB9420783A external-priority patent/GB9420783D0/en
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of FI964045A publication Critical patent/FI964045A/fi
Publication of FI964045A0 publication Critical patent/FI964045A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI964045A 1994-04-14 1996-10-09 CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä FI964045A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9407433A GB9407433D0 (en) 1994-04-14 1994-04-14 Heterocyclic derivatives
GB9420783A GB9420783D0 (en) 1994-10-14 1994-10-14 Heterocyclic derivatives
PCT/US1995/004163 WO1995028419A1 (en) 1994-04-14 1995-04-12 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines

Publications (2)

Publication Number Publication Date
FI964045A FI964045A (fi) 1996-10-09
FI964045A0 true FI964045A0 (fi) 1996-10-09

Family

ID=26304703

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964045A FI964045A0 (fi) 1994-04-14 1996-10-09 CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä

Country Status (25)

Country Link
EP (1) EP0756602B1 (cs)
JP (1) JPH09511223A (cs)
KR (1) KR970702274A (cs)
CN (1) CN1176646A (cs)
AT (1) ATE181737T1 (cs)
AU (1) AU697349B2 (cs)
BR (1) BR9507381A (cs)
CA (1) CA2186900A1 (cs)
CZ (1) CZ286764B6 (cs)
DE (1) DE69510545T2 (cs)
DK (1) DK0756602T3 (cs)
ES (1) ES2135722T3 (cs)
FI (1) FI964045A0 (cs)
GR (1) GR3031335T3 (cs)
HU (1) HUT76135A (cs)
IL (1) IL113365A (cs)
IS (1) IS4367A (cs)
MX (1) MX9604765A (cs)
NO (1) NO964348L (cs)
NZ (1) NZ283929A (cs)
PL (1) PL180026B1 (cs)
RU (1) RU2152939C1 (cs)
SK (1) SK281433B6 (cs)
TW (1) TW369529B (cs)
WO (1) WO1995028419A1 (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin
PE27497A1 (es) * 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
AU721081B2 (en) * 1996-12-10 2000-06-22 Zeria Pharmaceutical Co., Ltd. 1,5-benzodiazepine derivatives
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
CA2347938A1 (en) * 1998-10-20 2000-04-27 Takahiro Matsumoto 1,5-benzodiazepine compounds, their production and use
JP4535350B2 (ja) * 1998-11-17 2010-09-01 クミアイ化学工業株式会社 ピリミジニルベンズイミダゾール誘導体及び農園芸用殺菌剤
CN1678314A (zh) * 2002-08-27 2005-10-05 默克专利有限公司 作为raf－激酶抑制剂的甘氨酸酰胺衍生物
AP2006003768A0 (en) 2004-05-25 2006-10-31 Pfizer Prod Inc TetraazabenzoÄeÜazulene derivatives and analogs tehereof
CA2861024C (en) 2012-01-13 2020-09-22 Nippon Chemiphar Co., Ltd. P2x4 receptor antagonist
MA44007A (fr) 2016-02-05 2018-12-19 Denali Therapeutics Inc Inhibiteurs du récepteur interagissant avec protéine kinase 1
LT3552017T (lt) 2016-12-09 2022-05-10 Denali Therapeutics Inc. Junginiai, naudotini kaip ripk1 inhibitoriai
IL291985A (en) 2019-10-07 2022-06-01 Kallyope Inc gpr119 agonists
WO2023137035A1 (en) 2022-01-12 2023-07-20 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments
GB9201180D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
BR9507381A (pt) 1997-09-23
NO964348D0 (no) 1996-10-11
NO964348L (no) 1996-12-02
CN1176646A (zh) 1998-03-18
RU2152939C1 (ru) 2000-07-20
FI964045A (fi) 1996-10-09
AU697349B2 (en) 1998-10-01
WO1995028419A1 (en) 1995-10-26
SK130096A3 (en) 1997-08-06
ATE181737T1 (de) 1999-07-15
PL180026B1 (pl) 2000-12-29
CZ297296A3 (en) 1997-09-17
CA2186900A1 (en) 1995-10-26
MX9604765A (es) 1998-05-31
KR970702274A (ko) 1997-05-13
PL316870A1 (en) 1997-02-17
GR3031335T3 (en) 1999-12-31
IL113365A0 (en) 1995-07-31
JPH09511223A (ja) 1997-11-11
HU9602835D0 (en) 1996-12-30
TW369529B (en) 1999-09-11
NZ283929A (en) 1998-02-26
ES2135722T3 (es) 1999-11-01
EP0756602B1 (en) 1999-06-30
SK281433B6 (sk) 2001-03-12
IS4367A (is) 1996-09-30
DK0756602T3 (da) 2000-01-31
DE69510545T2 (de) 2000-01-13
EP0756602A1 (en) 1997-02-05
CZ286764B6 (en) 2000-06-14
DE69510545D1 (de) 1999-08-05
IL113365A (en) 1999-11-30
HUT76135A (en) 1997-06-30
AU2239095A (en) 1995-11-10

Similar Documents

Publication Publication Date Title
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
TR199800759T2 (xx) Protein Kinaz C �nhibit�r�.
AU6613896A (en) Chemical compounds
NZ330023A (en) Fused pyrrolecarboxanilides and their use as a GABA brain receptor ligands
ES2123149T3 (es) Derivados de perhidroisoindol como antagonistas de la substancia p.
MX9605128A (es) Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
FI964045A0 (fi) CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä
AU3025689A (en) Substituted 1,2,4-triazinediones, processes for their preparation and their use
DE69823493D1 (de) Tetrahydropyridoverbindungen
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
TR199701202T1 (xx) Yeni hidroksimik asit t�revleri.
DE69330601D1 (de) Serotoninergische ergolin derivate
SE9604582D0 (sv) Novel compounds
IL158356A0 (en) Benzoheterocycles
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
PT746556E (pt) Compostos triciclicos com afinidade para o receptor 5-ht1a
IL140919A0 (en) N-substituted azabicycloheptane derivatives, production and use thereof